ClinicalTrials.Veeva

Menu

Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care (PARKINSUN)

U

University Hospital, Lille

Status

Enrolling

Conditions

Parkinson's Disease

Treatments

Other: Consulting without PARKINSUN as communication aid-tool
Other: Consulting with PARKINSUN as communication aid-tool

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04179695
2018_74
2019-A01008-49 (Other Identifier)

Details and patient eligibility

About

PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult men and women with all stages of PD
  • Without severe chronic neurological or mental or psychiatric pathology
  • Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA > 22)
  • able to come (alone or accompanied) to consultation
  • Affiliate or beneficiary of a social security scheme
  • Subject having signed informed consent
  • Patient willing to comply with all procedures of the study and its duration

Exclusion criteria

  • Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent.
  • Subject under tutelage or curtailer.
  • Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

consultation with Parkinsun
Experimental group
Treatment:
Other: Consulting with PARKINSUN as communication aid-tool
consultation as usual without Parkinsun
Active Comparator group
Treatment:
Other: Consulting without PARKINSUN as communication aid-tool

Trial contacts and locations

1

Loading...

Central trial contact

David Devos, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems